2026-09-02

The latest addition is 《资治通鉴·汉纪》694丨《王命论》揭露东汉什么隐秘？, a 芮淇讲透资治通鉴 episode backfilling Jianwu 5 / 29 CE immediately before Hanji 695. It extends 班彪, 隗嚣, and 名实相符式名号节制, while connecting 天命合法性, 刘邦, 窦融, 陈英 / 陈婴, and 王陵母亲. Its core synthesis is that 王命论 is not an abstract literary set piece in this episode but a live adviser intervention: Ban Biao uses Han mandate continuity, Liu Bang’s founding capacity, failed claimant precedents, and family-preserving restraint examples to warn Wei Xiao against turning local strength into imperial ambition. No settled contradiction is recorded; the note qualifies the host’s destiny language as source-scoped and treats the episode as a fuller explanation of the 王命论 layer already previewed by Hanji 705-2.

The latest addition is 《资治通鉴·汉纪》693丨叛出刘秀的彭宠，如何因背叛而亡？, a 芮淇讲透资治通鉴 episode backfilling the Jianwu 5 / 29 CE layer immediately before Hanji 694 and Hanji 695. It adds 紫密, 庞萌, 不义之功封赏, and 疑心自生式叛乱, while extending 彭宠, 郭伋, 刘平, 班彪, and 贴身侍卫反噬. Its core synthesis is that early Guangwu consolidation is shown through internal reliability as much as battlefield pressure: Peng Chong’s rebel court collapses from trusted household proximity, Zi Mi’s reward exposes the legal problem of useful but unrighteous violence, Guo Ji rebuilds Yuyang through credibility and military preparation, Pang Meng rebels from unverified suspicion, Liu Ping turns subordinate loyalty into bodily protection, and Ban Biao frames Han restoration through the institutional difference between Zhou feudalism and Han commandery-county rule. No settled contradiction is recorded; 郭齐 is normalized to 郭伋, 庞蒙 to 庞萌, and minor household, campaign, and Man-leader names remain source-scoped.

The latest addition is VOL.221对话大白牛：掉肌肉、易抑郁、停药必反弹？撕掉“神药”滤镜, a 这病说来话长 episode with 阿汤 and 大白牛 on Continuous Glucose Monitoring, GLP-1 medicines, and health-data anxiety. It adds Wearable Health Data Anxiety / 可穿戴健康数据焦虑, while extending Continuous Glucose Monitoring, GLP-1 Agonists, Lifestyle Weight Management / 生活方式体重管理, Muscle As Longevity Infrastructure, Medical Risk Management, Personal Health Data, Information Cocoon / 信息茧房, 女性美貌自我监控 / Female Beauty Self-Surveillance, 阿汤 / A Tang, 大白牛老师 / Daba Niu Teacher, and 这病说来话长 / Zhe Bing Shuo Lai Hua Chang. Its core synthesis is that metabolic tools are useful when bounded by indication and context: CGM helps diabetes patients manage glucose swings and low-glucose risk, but healthy-person score-watching can create anxiety; GLP-1 drugs can help diabetes, obesity, and related metabolic disease, but unsupervised appearance use raises side-effect, muscle-loss, contraindication, mood, rebound, and long-term lifestyle risks. No settled contradiction is recorded; the episode reinforces VOL.217’s weight-management boundary while adding a sharper patient-facing GLP-1 and CGM caution.